Sonal Dharani

Sonal Dharani is a Research Associate at Cellectis, where responsibilities include developing next-generation Allogeneic CAR-T cell therapy and identifying attributes for Acute Myeloid Leukemia (AML) in CAR-T cell therapy. Prior experience includes a role as Senior Clinical Production Associate at Celgene, focusing on CAR T-cell therapy for Multiple Myeloma, and a Research Associate position at NYU Langone Health, working on computational biology for HIV and ZIKA. Additional roles involve a Research Specialist position at Rutgers University, studying the response of predatory bacteria to pathogens, and various student assistant and volunteer roles in research settings, emphasizing immunology, protein purification, and vaccine development. Sonal holds a Master of Science degree in Biomedical Sciences and a Certificate in Stem Cell Biology from Rutgers University–Newark.